Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Fat Embolism Syndrome: Evolving Perspectives on Diagnosis and Care

Shaikh N., Alali B., Amara UE., Nashrah UE., Alkheamy N., Ummunnisa F.

Narrative Review on Systemic / IV, published in Cureus (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Cureus (2025)
Reported sample size
—
Source database
Europe PMC
PMID
41356881
PMCID
PMC12679895
DOI
10.7759/cureus.96136

Abstract (original English)

Fat embolism syndrome (FES) is a rare clinical entity. Fat embolization in patients with trauma and long-bone fractures occurs in a majority of patients, and only a few patients develop the triad of skin petechia, respiratory distress, and neurological disturbances, which are termed FES. The exact incidence is not known, as there are no definitive criteria. All English-language publications about FES were searched and reviewed using Google Scholar, PubMed, various databases, conference proceedings, and abstracts, which were included in this study. FES is particularly underdiagnosed and underreported in body contour plastic surgery patients. The following two main theories of FES pathophysiology are proposed: mechanical and biochemical. There are various risk factors for FES, mainly in young patients and bilateral femoral fractures. The diagnosis of FES was traditionally a diagnosis of exclusion. Recently, the combination of clinical parameters and imaging studies has increased the accuracy of FES diagnosis. Point-of-care ultrasound can show fat particles floating from the inferior vena cava to the right heart. MRI is more specific in diagnosing FES with brain involvement. A high index of suspicion, combined with early imaging studies and the application of clinical criteria, must be used to diagnose FES early and accurately. Pharmacological treatments, ranging from ethanol to a

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research